STAT+: Closely watched experimental Parkinson’s drug fails key clinical trial
Stat News • 5/21/2026 – 5/22/2026
Summary
No summary yet.
Advertisement
Cluster Activity
1
2
2026-05-212026-05-22
Lindy Score Breakdown (V4.2)
17h
Age
1
Sources
from cluster
11
Hours Since Seen
Final Score11/100
CategoryAntiLindy
StatusActive
Recency Multiplier85% (0.5^11/48)
Hero EligibleYes
Story Timeline
- 2026-05-21STAT+: Closely watched experimental Parkinson’s drug fails key clinical trial (current)
- 2026-05-22
Score BreakdownRisk 70
Source Reputation: Low-trust source (4/20 pts)
Consensus: Single source - no independent confirmation yet
Age: Breaking news - too recent to assess longevity
Stories gain Lindy status through source reputation, network consensus, and time survival.
Same Story from 3 sources
Breaking Similar stories
STAT+: Pharmalittle: We’re reading about a Lilly obesity drug trial, statistics for an Alzheimer’s drug, and more
Stat News • 1 day ago
STAT+: Lilly’s ‘triple-G’ drug leads to bariatric-surgery levels of weight loss in trial
Stat News • 1 day ago
STAT+: Pharmalittle: We’re reading about a Parkinson’s drug setback, a Merck lung cancer therapy, and more
Stat News • Today
STAT+: Immunovant shares surge on arthritis trial data
Stat News • 1 day ago
STAT+: EU and US advisers split over AstraZeneca breast cancer drug
Stat News • Today
STAT+: Pioneering trial for treating genetic disease before birth nears reality
Stat News • 2 days ago
STAT+: Merck-Kelun lung cancer drug cut risk of tumor progression by 65%, ASCO abstract shows
Stat News • Today
STAT+: Pharmalittle: We’re reading about biotech investors’ mood, a former FDA head’s confidence, and more
Stat News • 2 days ago
STAT+: RFK Jr.’s screen time warning
Stat News • 1 day ago
STAT+: Longevity startup Retro Biosciences says latest fundraising values it at $1.8 billion
Stat News • Today
